Efficiencies of Transgene Expression in Nociceptive Neurons Through Different Routes of Delivery of Adeno-Associated Viral Vectors
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Transferring therapeutic genes into the nociceptive system, including dorsal root ganglia (DRGs) and the spinal cord, is potentially a powerful approach for the treatment of chronic pain in humans. Adeno-associated viral vectors (AAVs) are particularly useful in delivering foreign genes to targeted tissues because they seldom induce immune responses or produce cytotoxicity. To determine the efficiency of transgene expression and the best route(s) of delivery, a recombinant AAV type 2 vector containing the enhanced green fluorescent protein (EGFP) gene driven by the neuron-specific enolase (NSE) promoter (rAAV-EGFP) was constructed. We injected the vector into subcutaneous tissue, sciatic nerve, DRGs, and subarachnoid space, and examined EGFP expression in the DRG, spinal cord, and nerve fibers. Both sciatic nerve and DRG injection led to strong EGFP expression in a large number of DRG neurons. The expression persisted for more than 6-8 months. We then delivered the mu-opioid receptor (muOR) gene into DRGs through direct DRG or sciatic nerve injection of rAAV-muOR and found a significant increase in morphine efficacy. These results suggest that delivering therapeutic genes to DRGs by the rAAV-NSE vector is a valid strategy for treatment of chronic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381 · cited 2×
“Advances in construction of the AAV helper plasmid make it possible to produce high-titer AAV vectors in the absence of infectious helper adenovirus (Xiao et al ., 1998; Clark et al ., 1999; Zolotukhin et al ., 1999).”
Jooss, K., Yang, Y., Fisher, K. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4212-4223.1998 · Cited by 470 · cited 1×
“It can infect nondividing cells and integrate into the host cell genome (Samulski et al ., 1989) without signs of cytotoxicity (Kaplitt et al ., 1994; McCown et al ., 1996; Ferrari et al ., 1997; Jooss et al ., 1998).”
Chamberlin, N. L., Du, B., de Lacalle, S., & Saper, C. B. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00169-3 · Cited by 221 · cited 2×
“Earlier studies of rAAV vectors indicate that retrograde transduction rarely occurred in neurons of the brain (Chamberlin et al ., 1998; Zolo-tukhin et al ., 1999), although transgene expression was observed in the spinal cord after peripheral nerve injection (Boulis et al ., 2000).”
Cited by
Optogenetic Control of Targeted Peripheral Axons in Freely Moving Animals
Towne, C., Montgomery, K. L., Iyer, S. M., Deisseroth, K., & Delp, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072691 · Cited by 156
Recombinant Adeno-Associated Viral Vectors in the Nervous System
Burger, C., Nash, K., & Mandel, R. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.781 · Cited by 110
Optimization of AAV vectors to target persistent viral reservoirs
Colón-Thillet, R., Jerome, K. R., & Stone, D. (2021) · Virology Journal · doi:10.1186/s12985-021-01555-7 · Cited by 50
Pleticha, J., Heilmann, L. F., Evans, C. H., Asokan, A., Samulski, R. J., & Beutler, A. S. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-54 · Cited by 21
On the development of optical peripheral nerve interfaces
Anderson, H., & Weir, R. F. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.245461 · Cited by 14
“AAV2 (Xu et al., 2003), AAV5, AAV6, AAV8 and AAV9 (Yu et al., 2016) have all shown tropism for sensory neurons in the periphery.”
BackgroundInfluential
Metadata
- Authors
- Xu, Y., Gu, Y., Wu, P., Li, G.-W., & Huang, L.-Y. M.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2003-06-10
- Volume
- 14
- Issue
- 9
- Pages
- 897-906
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1998486048
- Cited by
- 76
- References
- 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficiencies of Transgene Expression in Nociceptive Neurons Through Different Routes of Delivery of Adeno-Associated Viral Vectors. https://app.cochat.ai/papers/10.1089/104303403765701187
- The paper
- Xu, Y., Gu, Y., Wu, P., Li, G.-W., & Huang, L.-Y. M. (2003). Efficiencies of Transgene Expression in Nociceptive Neurons Through Different Routes of Delivery of Adeno-Associated Viral Vectors. Human Gene Therapy. https://doi.org/10.1089/104303403765701187
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.